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A B S T R A C T
Tumors are evolving ecosystems where cancer subclones and the microenvironment interact. This is anal-
ogous to interaction dynamics between species in their natural habitats, which is a prime area of study
in ecology. Spatial statistics are frequently used in ecological studies to infer complex relations includ-
ing predator–prey, resource dependency and co-evolution. Recently, the emerging ﬁeld of computational
pathology has enabled high-throughput spatial analysis by using image processing to identify different
cell types and their locations within histological tumor samples. We discuss how these data may be ana-
lyzed with spatial statistics used in ecology to reveal patterns and advance our understanding of ecological
interactions occurring among cancer cells and their microenvironment.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
The interaction between cancer and surroundingnormal tissue plays
a vital role in the progression of malignant disease [1–7]. Obtaining a
continuous and suﬃcient supply of nutrients and oxygen [8] and the
threat of destruction by the adaptive immune response of the host [9]
are two of themajormicroenvironmental selection pressures faced by
cancer cells. Due to genetic heterogeneity within a tumor some ma-
lignant cells are able to survive under these pressures, thus becoming
‘naturally selected’ [10–15]. The ﬁtness advantages these cells havemay
include their ability to survive in hypoxic conditions [12,16,17], stim-
ulate new vessel growth [18–20] and modulate the host immune
response [2,21–23]. Such cells are adapted for a harsh microenviron-
ment and have been linkedwith poor prognosis [17,24,25]. Pioneering
research has revealed genetic changes in cancer cells during their evo-
lution [26–28], but there is developing interest in studying this process
from a novel perspective: ecology [29–31].
The synergy between cancer and normal cells is analogous to
relationships between species in a given habitat, which is a prime
area of study in ecology. These relationships have been systemat-
ically studied in four categories: (i) predation, where one species
beneﬁts by consuming another, (ii) mutualism, where two species
interact in a way that is of beneﬁt to both, (iii) commensalism, where
one species beneﬁts without any effect on the other, and (iv)
parasitism, where one species beneﬁts at the expense of the other
[32–34]. In cancer, all four of these relationships have been ob-
served or proposed to exist [5,30,35]. We propose that studies of
cell–cell interactions in the tumor ecosystem can substantially beneﬁt
from applying these ecological concepts and accompanying anal-
ysis tools that have been developed over many decades.
Ecological studies often begin with examining the spatial dis-
tribution of species in their habitats, which is a key determinant
in access to resources, predator evasion and interaction with other
organisms and the environment [36–39]. In tumors, spatial mapping
of cancer cells in their microenvironment can be achieved by anal-
ysis of histology samples [40–48]. However such specimen may
contain hundreds of thousands of cells that would be prohibi-
tively diﬃcult to count by eye, and estimates may vary between
observers [49]. In recent years, a new way of analyzing tumor spec-
imen has emerged in response to this challenge. Computer vision
techniques have been applied to pathology for automated identi-
ﬁcation and classiﬁcation of various cell types and tumor regions
[41,50–57] (Table 1), and can enable rapid mapping of their spatial
locations. For example, just as large areas of land can be mapped
for population density variation, a tumor sample may be pro-
cessed to map changes in density of its constituent cells, as shown
in Fig. 1 [58]. Such methods thus offer a new opportunity for study-
ing interactions between cancer and normal cells.
Although the notion of ecological interactions occurring in cancer
has been reviewed in great detail before [5,59], the application of
computational pathology to study these interactions is a novel ap-
proach in the ﬁeld of tumormicroenvironment research. This review
brings together three developing concepts with examples and ap-
plications: (i) ecological interactions among cancer cells and between
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Table 1
Computer vision tools developed for analysis of tumor histology images.
Authors, year Description Tissue Stain Accuracy Limitations
Basavanhally et al., 2010 [51] Lymphocytic inﬁltration detection and grading.
Support vector machine classiﬁer differentiates
between samples with high and low grade
inﬁltration.
Breast biopsy H&E >90% Derived from 42 images from 12 patients.
Does not provide lymphocyte locations for
spatial analysis, but could be adapted for
this.
Beck et al., 2011 [52] C-Path: categorizes regions in a histology image to
epithelial and stromal areas using 31 image-based
features. Further classiﬁcation of objects within
these areas using morphological and contextual
features. Can provide relational descriptors such as
mean distance between epithelial and stromal
nuclei.
Breast TMA H&E 89% Individual cells not detected. Classiﬁer may
need re-training before application to
datasets from other institutions.
Doyle et al., 2012 [53] Identiﬁcation of cancerous regions in an image
using a Bayesian classiﬁer that operates at
multiple resolution levels.
Prostate needle biopsy H&E ROC: 0.76-0.84 Patch-based rather than pixel-based
classiﬁcation recommended for high
resolutions. Spatial data cannot currently
be obtained.
Holmes et al., 2009 [54] GemIdent: identiﬁcation of multiple phenotypes
in a microscopic image. Uses supervised machine
learning algorithms for automated detection and
classiﬁcation of objects. Locations of objects are
also reported. Not limited to a particular stain or
tissue type.
Various Various Dependent on classiﬁer
training
User is required to train the program to
enable automated identiﬁcation. The
algorithm is best suited to images with few
colors. Detection of centroids of small and
large objects to identify their location may
be less reliable and require retraining of
the classiﬁer.
Lu et al., 2014 [55] ASH: automated selection of hotspots of Ki67+
stain. Region-based detection of Ki67+ areas in an
image using ImmunoRatio [56]. User is provided
with a ranked list of 10 hotspots. These areas are
labeled on the original image.
Various Ki67 Not stated Does not detect single cells. No
comparison to Ki67 hotspot scores by a
pathologist provided.
Tuominen et al., 2010 [56] ImmunoRatio: ratio of positive nuclear stain to
total nuclear area for an IHC marker. Each nucleus
is segmented and color deconvolution applied to
identify it as positive or negative.
Breast tissue sections ER, PR, Ki67, hematoxylin
counter-stain
Correlation coeﬃcient with
visual scoring = 0.98
Spatial data not provided but algorithm
could be adapted for this. Web-based
application may hinder high-throughput
analyses.
Yuan et al., 2012 [57] CRImage: identiﬁcation of cancer, lymphocyte and
stromal cells as well as their locations within the
tissue. Support vector machine classiﬁer uses
morphological and contextual features and
operates at multiple resolutions. Can be used to
obtain cellularity and lymphocytic abundance
scores, and cell location data enables spatial
pattern analysis.
Breast whole-tissue sections H&E >90% Only three types of cells detected: cancer,
lymphocyte and stromal. May suffer from
variability in staining and batch effects.
Potential application to other tissue types
but will require re-training.
This is a non-comprehensive list of some of the non-commercial methods available for automated detection of objects of interest in a tumor sample. Given also are the speciﬁc tissue and stain for which each method was
developed, the accuracy of the method reported by its authors and known limitations. H&E: hematoxylin and eosin; TMA: tissue microarray; ROC: receiver operating characteristic; ER: estrogen receptor; PR: progesterone
receptor.
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cancer and surrounding healthy tissue, (ii) the use of spatial sta-
tistics methods to study them in routine ecological investigations,
and (iii) computational pathology to explore the tumor microen-
vironment using these methods from a novel perspective.
Predation
Predation is a key component of an ecological system as it pre-
vents a single species from becoming dominant. In tumors, certain
Fig. 1. Versatile spatial mapping tools can be applied to study populations at both the macro- and micro-scales. Just as demographic surveys can reveal more and less densely
populated regions where, for example, a contagious disease may spread at different rates, image processing for identiﬁcation and location of different cell types in a tumor
can help elucidate the variation in cell density that may be used to develop new quantitative prognostic markers. (A) A satellite image of Ethiopia (left) and a correspond-
ing population density map (right). (Left: image by Michael Adams, distributed copyright-free; right: image by Yann Brolec, adapted and distributed under a CC-BY-SA 3.0
license.) (B) A hematoxylin and eosin (H&E)-stained whole-section sample of a breast tumor (left) with a corresponding cancer cell density map (right). Cell location data
were obtained from image processing of the whole-section sample using CRImage. (C) Analysis of H&E-stained breast tumor cells (left) using CRImage. The algorithm detects
the darkly stained cell nuclei and classiﬁes them into cancer, lymphocyte and stromal cell nuclei based on over a hundred quantitative features including nucleus texture
and morphology. It also provides location data for all nuclei detected, which can be used in cell mapping (right). (All H&E-stained tumor images shown are distributed with
permission from Natrajan et al., Breast cancer research and treatment, 2010).
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immune cells can locate and destroy cancer cells [60], analogous
to observations of predatory behavior frequently made in ecolog-
ical settings [61,62]. In ecology, spatial analyses of predator–prey
relations have been used to shed new light on predatory behavior
[63,64]. In one study, Ripley’s K statistic [65] (Table 2) was used to
evaluate the degree of uniformity in the distribution of hunting
murres in two foraging zones [66]. The authors found aggregation
of the birds in the two zones but a uniform distribution pattern
within these zones, suggesting a shift from maximizing coopera-
tion to minimizing competition over decreasing spatial distance as
the ecological principle driving their distribution. This study epito-
mizes the signiﬁcance of considering spatial scales in order to
evaluate the dynamics of predatory behavior.
A spatial analysis of immune cell distribution within a tumormay
reveal patterns indicative of the eﬃciency with which they can
inhibit tumor growth. A recent study of ours investigated the spatial
distribution of cancer and immune cells in breast tumors [67]. Cancer
and immune cell co-localization was quantitatively measured using
the Morisita–Horn index [68] (Table 2) following image analysis of
the histological specimen. TheMorisita–Horn index has been applied
in studying predator–prey interactions, since it quantiﬁes the extent
of co-localization between two or more species. For example, it was
used to investigate the theory of a positive association between pred-
ator body size and bothmean prey body size and prey diversity [69].
In our study, a high degree of co-localization between cancer and
immune cells measured by this index was found to be signiﬁ-
cantly associated with increased probability of ten-year disease-
speciﬁc survival in human epidermal growth factor receptor
2-positive (Her2+) breast cancers. This suggests a likely predator–
prey relation between cancer and certain immune cells in those
tumors. In another study on estrogen receptor-negative breast cancer
[47], we employed Getis–Ord geospatial statistics [70] (Table 2) that
can pinpoint areas with signiﬁcant spatial clustering or ‘hotspots’
of an entity. A high proportion of tumor regions containing hotspots
of both cancer and immune cells was associated with high disease-
speciﬁc survival in two independent patient cohorts, and provided
extra prognostic information to measures of immune abundance
[57]. Fig. 2 [58] displays results from a similar analysis in 180 triple-
negative breast tumors from the METABRIC dataset [71]. A possible
explanation is that this method is capturing, to some extent, spe-
cialized immune cells that play an anti-tumor role, and hence
increased co-localization with cancer cells is linked with higher sur-
vival probability. Both of these studies underline the importance of
utilizing the abundance of histology data to better understand the
ecological relationships between cancer and its microenvironment.
Indeed, previous studies of immune inﬁltrate in cancer have re-
vealed links between clinical outcome with immune cell presence
[32,42,44–46,72–76], relative abundance [57] as well as spatial prox-
imity of immune cells to invasive cancer cells [47,48,67,77,78] – the
concept of immune contexture. These ﬁndings indicate a stronger
tumor-inhibitory response of the immune system in patients with
a good clinical outcome. Viewing the anti-tumor activity of the
immune system from an ecological perspective as a predator–
prey interaction, spatial statistics methods routinely used in ecology
can be used to develop novel phenotypic prognosticators. This may
in turn shed further light on the complex interactions between cancer
and anti-tumor immune cells.
Mutualism
Mutualism deﬁnes a relationship between two species in which
both derive beneﬁt by interacting with each other, and plays a key
part in maintaining species ﬁtness [34]. A commonly observed
example of mutualism in nature is pollinators interacting with ﬂow-
ering plants. A recent study employed Mantel’s test [79] (Table 2)
to investigate bee variation and its association with spatially-
varying ﬂoral or nesting resources in an area of Mediterranean
scrubland [80]. The authors discovered that smaller bee popula-
tions tended to be aggregated in space while the twomost abundant
bee species were segregated, and that variation in bee composi-
tion could partially be explained by the change in ﬂoral resources.
Thus, a spatial analysis of bee distributions involvingmultiple factors
revealed signiﬁcant differences in how these pollinators interact with
ﬂowering plants.
Mutualistic interactions in cancer were thought to be rare as ma-
lignant cells face ﬁerce competition from each other for the limited
resources available [81]. However, one study reported coopera-
tion between two subclones in mouse mammary tumors: a luminal
HRas-wildtype subclone and a basal subclone harboring a somatic
HRas mutation [82]. Both were found to be favorable for tumor
growth. In another study, a mutualistic relationship between hypoxic
and non-hypoxic cancer cells was found [16]. Hypoxic cells me-
tabolized glucose to produce lactic acid which was unexpectedly
found to be a prominent respiratory substrate in non-hypoxic cancer
cells. Metabolizing lactic acid instead of glucose increased the avail-
ability of the latter for the hypoxic population which in turn
Table 2
Spatial statistics methods.
Method Description Limitations
Bayesian geospatial modeling Allows model parameter estimation given the data and prior knowledge
using a probabilistic approach (Bayes theorem) while accounting for
uncertainties. Can be used for making predictions and is robust for use in
large data sets.
Computationally demanding unless optimized.
Assumptions made from prior knowledge are subjective.
Getis–Ord hotspot score Identiﬁes points of signiﬁcantly high (hotspot) or low (coldspot)
occurrence of an object given the global mean. Takes neighbors into
account. Can be used to assess multivariate point patters. Can distinguish
between high positive and low positive spatial autocorrelation.
Not suitable for identifying negative spatial
autocorrelation.
Mantel test Measures correlation between two matrices of the same rank
(dimensions). Matrices typically contain distance measures between each
pair of species in the sample set. Partial Mantel test can take into account
a third or multiple other matrices containing confounding factors.
Unreliable for complex non-linear relationships between
distances.
Morisita–Horn index Measures the dissimilarity in species between two locations. Returns a
value in the range 0 (no similarity) to 1 (complete similarity).
Sensitive to the most abundant species.
Ripley’s K statistic Global summary statistics. Measures spatial clustering or dispersion in a
point pattern over small and large distances. Identiﬁes how a distribution
differs from homogeneity. Can be extended to analyze multivariate point
patterns.
Cannot be used to account for continuous quantitative
values associated with points, unless ﬁrst discretized.
Spatial statistics offers numerous methods that can be used for analyzing ecological relationships. Listed here are those mentioned in the text, alongside their descriptions
and limitations.
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generated an acidic environment that is thought to be immuno-
suppressive, thereby helping both populations to evade immune-
mediated destruction. Other examples of cooperative behavior
among cancer cells can also be found in the literature [83–85]. Thus,
the relationship between cancer cells in a tumor is not always com-
petitive; cooperative interactions may also evolve where the beneﬁt
derived from each other outweighs the need to compete.
Mutualistic relationships have also been found to occur between
cancer and its microenvironment. A computational model of tumor-
immune interactions proposed how signals produced by M2
macrophages may be promoting tumor viability at early stages of
disease development [86]. TheM2macrophages beneﬁt, in turn, from
tumor-derived chemokines that promote the switch fromM1mac-
rophage to the M2 phenotype [87]. The relationship between cancer
cells and blood vessels can also be considered as mutualistic and
analogous to that between bees and ﬂowers. In return for obtain-
ing essential resources from existing blood vessels, cancer cells can
release angiogenic factors to promote new vascular growth. Just as
ﬂoral resource distribution can partially account for the variance
in bee composition within a habitat, spatial analysis of tumor spec-
imen may reveal whether variance in resource distribution offers
a survival advantage to some cells. Existingmethods for vessel quan-
tiﬁcation using histology samples [88,89] could be adapted and/
or combined with cell detection algorithms [57,90] to evaluate the
spatial relationship between the two and its impact on patient
prognosis.
Commensalism
Commensalism describes the interaction of two species whereby
one gains a ﬁtness advantage while the other neither beneﬁts nor
is harmed [34], though proving a lack of effect on the latter is often
diﬃcult. For example, urban rats typically have a commensal rela-
tionship with humans while they remain underground and feed on
human waste. This relationship changes when rats cause harm to
people by infesting homes, damaging property and transmitting dis-
eases, the likelihood of which increases with urbanization. In one
study, the authors sampled rat populations in an inner-city neigh-
borhood over a year and used Getis–Ord spatial statistics to identify
rat hotspots, i.e. regions where there were signiﬁcantly higher
numbers of rats found than one would expect given their overall
spatial distribution [91]. Such studies allow urban health investi-
gators to make more informed sampling choices in monitoring rat
populations as cities expand.
In cancer, commensal relationships have been reported between
tumor subclones. In one study, insulin-like growth factor II (IGF-
II)-producing and non-producing cancer cells were observed to be
in stable co-existence [92]. IGF-II non-producing cells gained an
Fig. 2. Data derived from image processing of tumor sections can be used in spatial pattern analysis for discovery of new prognostic markers. Many spatial statistics methods
developed for point pattern analysis can be applied to the study of tumor cells. Here, Getis–Ord hotspot analysis has been used to identify statistically signiﬁcant co-
localized clusters of cancer and immune cells that are prognostic in a cohort of tripe-negative breast cancer (TNBC) patients. (A) A H&E-stained breast tumor whole section.
(B) Co-localized cancer-immune hotspots map for the tumor in A, constructed using cell locations obtained from CRImage and applying the Getis–Ord hotspot detection
algorithm. (C) High resolution example of a hotspot region. (D) Kaplan–Meier curve illustrating ten-year disease-speciﬁc survival of 180 TNBC patients. Hotspot score is the
ratio of hotspot to non-hotspot area in a sample. A high hotspot score, deﬁned as being greater than a threshold discovered and validated in independent patient groups,
correlates signiﬁcantly with good prognosis. (All H&E-stained tumor images shown are distributed with permission from Natrajan et al., Breast cancer research and treat-
ment, 2010).
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advantage by obtaining IGF-II from producers without beneﬁting
or harming them in any way. The authors also considered the dif-
fusion range of a growth factor in a simulation to show that for
greater ranges, the producer population diminished as increasing
numbers of non-producers began to take advantage. Thus the es-
tablishment of equilibrium is conditional and has important
implications for therapies that target growth factors.
Cancer cells also form commensal relationships with their mi-
croenvironment. For example, cancer-associated ﬁbroblasts (CAFs)
are known to support tumor growth and progression [93–95].
CXCL12, a chemokine secreted by CAFs, can stimulate angiogen-
esis and increased proliferation in cancer cells [6], while tumor
growth factor-β signaling in CAFs is also known to modulate tumor
proliferation [96]. This commensal relationship has begun to attract
increasing interest in research as it is considered to play a vital role
in metastasis [20]. The study of commensalism between subclones
as well as the tumor and tumor-promoting traits of the microen-
vironment can reveal important inter-dependencies that may
inﬂuence patient outcome or response to treatment. A mathemat-
ical model of cancer invasion suggests harsh microenvironmental
conditions, such as hypoxia and a heterogeneous extracellularmatrix,
promote aggressive phenotypes with a high potential of metasta-
sis [97]. With the aid of hypoxia or M2macrophage-speciﬁc markers
and spatial analysis of cancer cells with respect to positive and neg-
ative regions, these claims may be further substantiated by
experimental evidence.
Parasitism
Parasitism differs from predation in that although a parasite
harms its host, the host is not usually destroyed. A tumor can be
considered as a parasite in the living organism despite not being a
distinctly different species [98]. Like parasites, cancer cells undergo
rapid proliferation and harm their host, by metastasizing to and de-
stroying local and distant healthy tissue. However, since cancer
cannot be transmitted or inherited, unlike many parasites, there is
no selection pressure to keep the host alive. In one study, Bayes-
ian predictive modeling [99] (Table 2) was used to identify
environmental factors associated with parasites that can lead to
learning diﬃculties in children in northwest Tanzania [100], whilst
accounting for any spatial correlation that may exist between these
factors. Bayesian modeling is a powerful predictive tool as it can
account for spatial correlation in the data, preventing overestima-
tion of the signiﬁcance of predictors and the conﬁdence of prediction.
The results of this study demonstrate the importance of consider-
ing spatial relationships between predictors for robust predictive
modeling. Such an approach may be applied in tumor analysis to
study the parasitic role of cancer, and by considering environmen-
tal and spatial features, driving factors may be differentiated from
confounding factors.
The reverseWarburg effect is a manifestation of the parasitic be-
havior of cancer [101,102]. This model proposes stimulation of
ﬁbroblasts by epithelial cancer cells to undergo aerobic glycolysis
and release high-energy metabolites such as lactate. These me-
tabolites facilitate rapid tumor proliferation as they can be
metabolized in mitochondria, a more energy eﬃcient mechanism
of producing ATP than standard glycolysis. Thus, the tumor drives
high-energy substrates away from healthy tissue for its own sus-
tenance, analogous to a parasite, and unlike CAFs forming commensal
relationships with cancer, ﬁbroblasts involved in the reverseWarburg
effect are often destroyed in the process via autophagy. Based on
the model, it is predicted that a large stromal content of a tumor
should be associatedwith rapid tumor growth, metastasis and a poor
prognosis. To seek experimental veriﬁcation, computational tools
developed for quantifying stromal content in cancer histology
samples can be applied for obtaining precise and reproducible
measurements for comparison to clinical outcome data. In partic-
ular, spatial pattern analysis of cancer and stromal cells may add
further prognostic power to such a model.
Current challenges and future outlook
There are some disparities between natural ecological settings
and the tumor microenvironment that should be considered when
applying ecological methods to the study of cancer. Ecological in-
teractions in the tumor differ in some respects to those between
multicellular organisms that reproduce sexually. Unlike these or-
ganisms, cancer cells do not require co-localization with each other
to produce new cells. However, the high rate of accumulation of mu-
tations due to the inherent genetic instability in cancer cells may
have an effect on their ecological interactions with the microenvi-
ronment that is diﬃcult to model. Highly proliferative cancer cell
populations undergoing mitotic cell division will pass on acquired
mutations to every daughter cell, hence sustaining a rapidly evolv-
ing population with a greater degree of niche heterogeneity at any
one instance than is present in animal populations [81]. Detecting
this heterogeneity while preserving the spatial context to con-
struct computational models of cell ecology presents a technical
challenge.
One of the drawbacks of computational analysis of histological
material is the inability to distinguish between all features of in-
terest using the same software. An image processing tool developed
for hematoxylin and eosin (H&E)-stained images will not, in general,
be applicable to immunohistochemistry (IHC) images; however, one
may wish to incorporate the additional information provided by IHC
to that obtained from H&E stains. Development of robust comput-
er vision tools capable of analyzing images from different tissue stains
could play a key role in propelling computational pathology into
mainstream research and clinical use. This is especially important
for the latter as variation in patient outcome despite current prog-
nosticators remains a puzzle.
Moreover, histology on its own can be limited by the two-
dimensional representation of a three-dimensional entity. Radio-
imaging modalities can step in to address this problem [103].
Integrating radio-imaging data along with a variety of assays in-
cluding IHC, immunoﬂuorescence and DNA/RNA in situ hybridization,
which can be used to reveal complex spatial patterns at protein, RNA
and genetic levels [104–109], will provide additional layers of in-
formation to phenotypic characteristics obtained from H&E images.
Studying the spatial structure of the tumor in this way may reveal
new cancer–cancer or cancer–microenvironment interactions, such
as those reported in [86,97], that exist at different spatial scales and
could be exploited for patient beneﬁt.
Summary
There is strong evidence of ecological phenomena occurring in
the tumor microenvironment, and phenotypic studies of these phe-
nomena can beneﬁt greatly from application of spatial statistics tools
routinely employed in ecological studies. Histology samples can
provide an abundance of data as input for these methods due to
the preserved spatial context. With the aid of computer vision in
pathological research, this is becoming increasingly feasible to
achieve, resulting in the emergence of new prognosticators for clin-
ical use with potential to advance personalized therapy. Spatial
pattern analysis empowered by integration of multiple layers of in-
formation could facilitate a more in-depth study of ecological
interactions in the tumor and may prove to be successful in ex-
plaining the heterogeneity in clinical outcome. This could aid in
identiﬁcation of patients at highest risk of treatment failure who
may beneﬁt from participation in new clinical trials.
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